BTAI  220414C00025000

Sold 50% of BTAI $25 Calls

This member connected a brokerage account and is sharing trades and portfolio performance with the community. 

Public Portfolio

Abilash Satya

Sold 33% of BTAI $25 Calls

Bought 50% more BTAI $25 Calls

Bought 100% more BTAI $25 Calls

Bought BTAI $25 Calls

bioxcel therapeutics, inc. is a clinical stage biopharmaceutical company focused on drug development that utilizes novel artificial intelligence to identify the next wave of medicines across neuroscience and immuno-oncology. the company's drug re-innovatio

BioXcel Therapeutics, Inc. Common Stock

Sold all BTAI

Mike Pelech

New position in BTAI

Brendan Mahoney

Sold 50% of BTAI

Bought 4% more BTAI

Bought 109% more BTAI

Bought 28% more BTAI

Bought 16% more BTAI

Brice Landry

Bought 3% more BTAI

Bought 20% more BTAI

Bought 100% more BTAI